IN8BIO, INC. — Director's Dealing 2023

Apr 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2023-04-14

Reporting Person: McCall Patrick (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-14	Employee Stock Option (right to buy)	$1.22	A	200000	Acquired	2033-04-14	Common Stock (200000)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.